LRPAP1
Reaktivität: Human
IHC
Wirt: Kaninchen
Polyclonal
unconjugated
Applikationshinweise
Dilution: 1:50 - 1:100 (WB)
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Buffer
serum
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C/-20 °C
Target
LRPAP1
(Low Density Lipoprotein Receptor-Related Protein Associated Protein 1 (LRPAP1))
Andere Bezeichnung
RAP
Hintergrund
The antibody binds to an epitope of the C-terminal part of RAP, a sequence common to the human VLDL receptor superfamily (glycoprotein 330 and LRP), the chicken oocyte receptor for VLDL and vitellogenin (LR8), and glycoprotein 330/megalin from rat. No reaction with LDL receptor. The antibody interferes with binding of VLDL and vitellogenin receptor. Binding is Ca2+-dependent with LR8.